Prediction of Sustained Virological Response to Peginterferon-based Therapy for Chronic Hepatitis C: Regression Analysis of a Cohort from Rio Grande do Sul, Brazil

AIM: Peginterferon plus ribavirin (peg-IFN/RBV) is still the standard of care for treatment of hepatitis C virus (HCV) in many countries. Given the high toxicity of this regimen, our study aimed to develop a prediction tool that can identify which patients are unlikely to benefit from peg-IFN/RBV an...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Euroasian J Hepatogastroenterol
Main Authors: V Picon, Rafael, Fendt, Lúcia, Amaral, Karine, D Picon, Paulo
Formato: Artigo
Idioma:Inglês
Publicado em: Jaypee Brothers Medical Publishers 2017
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5663770/
https://ncbi.nlm.nih.gov/pubmed/29201768
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5005/jp-journals-10018-1207
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados